Kerri Mowen
Fundador en Padlock Therapeutics, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Michael Gilman | M | 69 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 años |
Todd A. Huffman | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 años |
David Grainger | M | 58 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Roel Bulthuis | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 10 años |
Michael Gladstone | M | 37 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Marian Nakada | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Paul Thompson | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Rab Prinjha | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Faat Ting Cheng | M | 56 |
Southern Illinois University
| 6 años |
Muhammad Khilji | M | 58 |
Southern Illinois University
| 6 años |
Sarah Gabriel | F | - |
Southern Illinois University
| 4 años |
Craig D. Nelson | M | 70 |
Southern Illinois University
| 4 años |
Andrew White | M | - |
Southern Illinois University
| 2 años |
April Pica | F | - |
Southern Illinois University
| 4 años |
Amanda Black | F | 48 |
Southern Illinois University
| 4 años |
Janet Torrisi-Mokwa | F | - |
Southern Illinois University
| 5 años |
Mohammed Saud Abdul Aziz Al-Badr | M | 65 |
Southern Illinois University
| 3 años |
Christopher Hartman | M | 54 |
Southern Illinois University
| 4 años |
Jerry L. Greene | M | - |
Southern Illinois University
| 4 años |
Teresa Katubig | F | - |
Southern Illinois University
| 4 años |
Steve Cotone | M | - |
Southern Illinois University
| 4 años |
Rajesh Devraj | M | - |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 1 años |
Daniel Furey | M | - |
Southern Illinois University
| 4 años |
Abdul Rahman Al-Ismail | M | - |
Southern Illinois University
| 1 años |
Ufuk Ince | M | - |
Southern Illinois University
| - |
Lilia Mavrikova | F | - |
Southern Illinois University
| 2 años |
Mariana Nacht | M | 60 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | 2 años |
Mehmet Ali Cer | M | - |
Southern Illinois University
| 3 años |
Hsing-Yen Tsai | M | 59 |
Southern Illinois University
| 1 años |
Ivo Vassilev Ivanov | M | - |
Southern Illinois University
| 1 años |
Shuo-Wei Shih | M | 55 |
Southern Illinois University
| 4 años |
Siu Fung Chiu | F | 55 |
Southern Illinois University
| 2 años |
William Mirecki | M | 53 |
Southern Illinois University
| 4 años |
Matthew Warrens | M | - |
Southern Illinois University
| 4 años |
Jeff Vivacqua | M | - |
Southern Illinois University
| 5 años |
James McCormick | M | 57 |
Southern Illinois University
| 2 años |
Walid Abanumay | M | 57 |
Southern Illinois University
| 3 años |
Sean Loving | M | - |
Southern Illinois University
| 4 años |
Terry Hart | M | 55 |
Southern Illinois University
| 5 años |
James Eric Mineman | M | - |
Southern Illinois University
| 5 años |
Lisa Ann Teter | F | - |
Southern Illinois University
| 5 años |
Troy Ward | M | - |
Southern Illinois University
| 4 años |
Kailash Birmiwal | M | - |
Southern Illinois University
| 7 años |
Scott Thoma | M | - |
Southern Illinois University
| 4 años |
Eric Sites | M | 45 |
Southern Illinois University
| 4 años |
Adelene Perkins | F | 54 |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | - |
Teri Lesicko | F | - |
Southern Illinois University
| 2 años |
John Henkhaus | M | - |
Southern Illinois University
| 4 años |
Robert Hess | M | - |
Southern Illinois University
| 2 años |
Eryn Lampe | F | - |
Southern Illinois University
| 3 años |
John Theodore Sanders | M | 82 |
Southern Illinois University
| 5 años |
Ken M. Loveless | M | - |
Southern Illinois University
| 4 años |
Don W. Adams | M | - |
Southern Illinois University
| 4 años |
Richard Marincic | M | - |
Southern Illinois University
| 4 años |
Kelly M. Malson | F | 53 |
Southern Illinois University
| 4 años |
Xiao Yang Yu | M | 70 |
Southern Illinois University
| 2 años |
Tim Vediz | M | - |
Southern Illinois University
| 4 años |
Christopher K. Davies | M | 66 |
Southern Illinois University
| 4 años |
Yun Fei Chen | M | 52 |
Southern Illinois University
| 3 años |
Robert Berry | M | - |
Southern Illinois University
| 3 años |
Jian Wen Liao | M | 57 |
Southern Illinois University
| 3 años |
Shelton Frey | M | - |
Southern Illinois University
| 3 años |
Raghu Iyer | M | - |
Southern Illinois University
| 3 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 63 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Kerri Mowen
- Red Personal